Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - GROSS PROFIT
Gross Profit REGN - Regeneron Pharmaceuticals, Inc.
11.3 B
LAST VALUE
-8.96%
2 YEAR CAGR
12.48%
5 YEAR CAGR
19.21%
10 YEAR CAGR